Iron Deficiency Anemia
📧 Sign up to get email alerts when something new happens for Iron Deficiency Anemia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-25EMA Authorised: Feraccru (ferric maltol) — Norgine B.V.
EMA authorised Feraccru (ferric maltol) for iron-deficiency anemia, with Norgine B.V. as marketing authorisation holder.
-
FDA approval · 2026-03-02FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
The FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc.
-
FDA approval · 2025-12-19FDA Approved: ACCRUFER — Supplemental Application (Shield TX (UK) Ltd)
The FDA approved a supplemental application for ACCRUFER (ferric maltol) submitted by Shield TX (UK) Ltd.
-
FDA approval · 2025-10-16FDA Approved: FERABRIGHT — Original Application (Azurity Pharmaceuticals, Inc.)
FERABRIGHT (ferumoxytol) has FDA approval under its Original Application filed by Azurity Pharmaceuticals, Inc. for the treatment of iron de…
-
FDA approval · 2025-09-22FDA Approved: IRON SUCROSE — Supplemental Application (Sandoz Inc)
FDA approves a supplemental application for iron sucrose from Sandoz Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-09-09FDA Approved: SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Hikma Pharmaceuticals USA Inc. to market a generic sodium ferric gluconate complex in sucrose. T…
-
FDA approval · 2025-08-08FDA Approved: IRON SUCROSE — Original Application (Mylan Institutional LLC)
FDA approved the original application for Iron Sucrose, a generic injectable iron product, indicating approval for use in treating iron defi…
-
FDA approval · 2025-08-08FDA Approved: IRON SUCROSE — Original Application (International Medication Systems, Limited)
FDA approved a generic iron sucrose injection from International Medication Systems as an Original Application (ANDA 208977).
-
FDA approval · 2025-08-08FDA Approved: IRON SUCROSE — Original Application (Sandoz Inc)
FDA approved Sandoz's iron sucrose original application, enabling the generic iron replacement product to be marketed.
-
FDA approval · 2024-08-01FDA Approved: MONOFERRIC — Supplemental Application (Pharmacosmos Therapeutics Inc.)
FDA approves a supplemental application for MONOFERRIC (ferric derisomaltose) from Pharmacosmos Therapeutics Inc., resulting in changes to t…
-
FDA approval · 2024-08-01FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc.
-
FDA approval · 2024-08-01FDA Approved: INFED — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for INFED (iron dextran) submitted by Allergan, Inc.
-
EMA approval · 2023-12-18EMA Authorised: Feraccru (ferric maltol) — Norgine B.V.
Feraccru (ferric maltol) has been authorised in the EU for iron deficiency anemia, expanding options for treatment of iron-deficiency anemia…
-
FDA approval · 2023-05-31FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for Injectafer (ferric carboxymaltose injection) submitted by American Regent, Inc.
-
FDA approval · 2022-09-08FDA Approved: ACCRUFER — Supplemental Application (Shield TX (UK) Ltd)
The FDA approved a supplemental application for ACCRUFER (ferric maltol) filed by Shield TX (UK) Ltd. This action likely updates labeling or…
-
FDA approval · 2022-08-04FDA Approved: MONOFERRIC — Supplemental Application (Pharmacosmos Therapeutics Inc.)
FDA approved a supplemental application for MONOFERRIC (ferric derisomaltose) from Pharmacosmos Therapeutics Inc.
-
FDA approval · 2022-06-16FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
FDA approved a supplemental application for Feraheme (ferumoxytol) from AMAG Pharmaceuticals.
-
FDA approval · 2022-06-01FDA Approved: ACCRUFER — Supplemental Application (Shield TX (UK) Ltd)
The FDA approved a supplemental application for ACCRUFER (ferric maltol) submitted by Shield TX (UK) Ltd.
-
FDA approval · 2022-02-16FDA Approved: ACCRUFER — Supplemental Application (Shield TX (UK) Ltd)
FDA approved a supplemental application for ACCRUFER (ferric maltol) submitted by Shield TX (UK) Ltd. The action concerns an existing approv…
-
FDA approval · 2022-02-04FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for Injectafer (ferric carboxymaltose injection) submitted by American Regent, Inc.
-
FDA approval · 2021-11-19FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for Injectafer (ferric carboxymaltose injection) from American Regent, Inc., resulting in an approve…
-
FDA approval · 2021-09-14FDA Approved: INFED — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for INFED (iron dextran) from Allergan, Inc.
-
FDA approval · 2021-08-04FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approves a supplemental application for Injectafer (ferric carboxymaltose injection) submitted by American Regent, Inc.
-
FDA approval · 2021-04-28FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for Injectafer (ferric carboxymaltose injection) from American Regent, Inc. The approval pertains to…
-
FDA approval · 2021-04-20FDA Approved: INFED — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for INFED (iron dextran) submitted by Allergan, Inc. This action authorizes changes to the product u…